Long-term clinical outcome of helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma is comparable to that of h. pylori-positive lymphoma

J Clin Gastroenterol. 2009 Apr;43(4):312-7. doi: 10.1097/MCG.0b013e31816a48f8.

Abstract

Goals and background: Little is still known regarding the clinical features and prognosis of gastric mucosa-associated lymphoid tissue (MALT) lymphoma without Helicobacter pylori (H. pylori) infection.

Study: From January 1996 to April 2006, a total of 185 patients with gastric MALT lymphoma were enrolled at Seoul National University Hospital. To assess the differences in clinical characteristics and long-term outcomes between H. pylori-negative (n=29, 15.7%) and H. pylori-positive (n=156, 84.3%) cases, we compared these 2 types of lymphoma.

Results: The overall median follow-up period was 39 months. There were no significant differences between the 2 groups in terms of age, macroscopic phenotype, or histologic grade. H. pylori-negative group showed male predominancy (72.4%) and higher percentage of proximal stomach location (62.1%). Although H. pylori-negative lymphomas were more frequently presented as advanced disease (stage IIE or IV, 37.9%), no significant differences in both the overall complete response and overall survival rates were observed between the 2 groups.

Conclusions: Our results suggest that H. pylori-negative gastric MALT lymphoma shows a favorable long-term outcome, which is comparable to that of H. pylori-positive lymphoma.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Female
  • Gastric Mucosa / microbiology
  • Gastric Mucosa / pathology
  • Helicobacter Infections* / complications
  • Helicobacter Infections* / microbiology
  • Helicobacter Infections* / mortality
  • Helicobacter Infections* / pathology
  • Helicobacter pylori / isolation & purification
  • Humans
  • Lymphoma, B-Cell, Marginal Zone* / microbiology
  • Lymphoma, B-Cell, Marginal Zone* / mortality
  • Lymphoma, B-Cell, Marginal Zone* / pathology
  • Male
  • Middle Aged
  • Prognosis
  • Stomach Neoplasms* / microbiology
  • Stomach Neoplasms* / mortality
  • Stomach Neoplasms* / pathology
  • Survival Analysis
  • Survival Rate
  • Time Factors
  • Young Adult